Skip to content
Homepage
Author:
Amphastar Pharmaceuticals, Inc.
Posted Date:
May 27, 2026
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
Amphastar Pharmaceuticals, Inc.
May 27, 2026
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026
Amphastar Pharmaceuticals, Inc.
May 8, 2026
Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference
Amphastar Pharmaceuticals, Inc.
May 6, 2026
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026
Amphastar Pharmaceuticals, Inc.
April 30, 2026
Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference
Amphastar Pharmaceuticals, Inc.
April 6, 2026
Amphastar Pharmaceuticals to Present at the Barclays 28th Annual Global Healthcare Conference
Amphastar Pharmaceuticals, Inc.
March 4, 2026
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025
Amphastar Pharmaceuticals, Inc.
February 27, 2026
Amphastar Announces FDA Approval for Ipratropium Bromide HFA
Amphastar Pharmaceuticals, Inc.
February 24, 2026
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026
Amphastar Pharmaceuticals, Inc.
February 20, 2026
